Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

South Korea Antitrust Fine

South Korea’s Fair Trade Commission fined GlaxoSmithKline three billion won (approx. US$2.6 million) for conspiring with a Seoul rival over the sale of drugs. According to the South Korean government, Glaxo in 2000 offered Dong-A Pharmaceutical the exclusive right to sell its anti-nausea drug Zofran and an anti-viral medication called Valtrex; in return, Glaxo demanded that Dong-A stop selling a cheaper generic version of Zofran and not produce or sell any drugs that could compete against Zofran and Valtrex.

Misconduct Type
Antitrust
Enforcement Agency
International
Contracting Party
None
Court Type
N/A
Disposition
Fine
Date of Fine Announcement
10/27/2011
Contractors Involved Penalty
Total
GlaxoSmithKline $2,651,737
Further Information Released

Federal Contractor Misconduct Database